Keywords: japan, pharma, stocks, week, sept, 3rd, tokyo
Japan pharma stocks, week to Sept 3rd
Article | 05 September 2001
Tokyo saw another steep retreat in the week ending Monday September 3with the Nikkei 225 tumbling 7.7% to 10,409.68, below the 10,500 mark for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
